Shares of Abbott Laboratories ABT slipped 1.29% to $132.28 Tuesday, on what proved to be an all-around dismal trading session ...

Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to ...

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Abbott Laboratories (NYSE:ABT) is one of the best stocks to buy for beginners now. On June 10, Tandem Diabetes Care Inc.

Abbott Laboratories (NYSE: ABT) is one of the 17 stocks that Jim Cramer commented on. During the episode, Cramer was bullish ...

Abbott Laboratories has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has ...

According to Benzinga Pro, Abbott Laboratories's peer group average for short interest as a percentage of float is 5.50%, which means the company has less short interest than most of its peers. Did ...

In the Legislature’s sloppy law attempting to ban cannabis products with THC, the punishment could be worse than the crime. | ...

Tandem Diabetes Care, Inc. recently announced a significant collaboration with Abbott Laboratories (NYSE:ABT) to integrate Abbott's upcoming dual glucose-ketone sensor with Tandem’s insulin delivery ...

Abbott remains a Buy at $131 for its steady cash flow, strong fundamentals, and long-term healthcare growth, despite short-term revenue concerns. Wall Street underestimates ABT's operational ...